Rare Cancers: The Time to Act is Now
Date held: April 11th, 2019
Presented by: Durhane Wong-Rieger, President & CEO of Canadian Organization for Rare Disorders and Lisa Machado, Founder and Chair of the CML Network
Webinar Information:
Diagnostic breakthroughs like genome sequencing make earlier stage diagnosis possible and breakthroughs in personalized treatment, including cell and gene therapies, provide new hope, including potential cures.
CCSN welcomed our host panelist Durhane Wong-Rieger, President & CEO of Canadian Organization for Rare Disorders and Chair of Rare Disease International. Durhane was joined by Lisa Machado, Founder and Chair of the CML Network for this engaging and educational webinar on the unique issues presented in rare cancers.
The webinar was followed by a question & answer session.
The slides are available on our Slideshare account here.